New Blood Test Measures Progression of Alzheimer's Disease

Researchers have developed a new blood test that helps show how far Alzheimer's disease has progressed in the brain. The test was unveiled at the Clinical Trials on Alzheimer's Disease conference in Boston, Massachusetts.
The test, developed by Alamar Biosciences, measures levels of a biomarker called (MTBR-tau) that reflects the accumulation of tangled tau protein in brain cells.
Currently available blood tests for Alzheimer's measure proteins such as beta amyloid and phosphorylated tau, whose levels rise in the early stages of the disease, but they provide only limited information about the accumulation of tau protein tangles in later stages.
There are also two Alzheimer's drugs on the market designed to reduce beta amyloid plaques in the brain, while several medications targeting tau protein are under development.
● Notice to (new) website visitors:You can subscribe to news via WhatsApp for freeClick hereto receive everything new and exclusive.Source akhbaar24